Tuesday, November 13, 2012

Mesothelioma Drug Slows Disease Progression in Patients With an Inactive NF2 Gene

A new drug gives hope to mesothelioma cancer patients.

Initial results from the preliminary trial of a new drug for patients with mesothelioma could reveal that it shows some success in preventing the spread of the deadly disease in patients with low active tumour suppressor gene called NF2, reports Science Daily.

No comments:

Post a Comment